Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Mar 3.
Published in final edited form as: Pediatr Dermatol. 2020 Oct 16;38(1):83–87. doi: 10.1111/pde.14405

Duration of neonatal intensive care unit exposure associated with decreased risk of atopic dermatitis

Jennifer J Schoch 1, Nicole Miranda 2, Cynthia W Garvan 3, Reesa L Monir 1, Josef Neu 4, Dominick J Lemas 5
PMCID: PMC8892389  NIHMSID: NIHMS1778647  PMID: 33063877

Abstract

Background/Objectives:

Premature infants have lower rates of atopic dermatitis (AD) compared with full-term infants, though little is known about the factors contributing to this association. We explored the infant and environmental factors that may contribute to the association between prematurity and atopic dermatitis, including mode of delivery, birthweight, gestation, and duration of stay in the neonatal intensive care unit (NICU).

Methods:

This was a single-center retrospective study. Independent samples t tests or chi-square tests were used to compare groups on continuous and categorical variables, respectively. Logistic regression then examined the association of the predictor variables with AD.

Results:

Four thousand sixteen mother-infant dyads were included. Infants had a higher risk of developing AD if they were delivered vaginally (P = .013), did not stay in the NICU (P < .001), had a longer gestation (P = .001), or had a higher birthweight (P = .002). In modeling atopic dermatitis with the predictor variables, only NICU length of stay remained significantly associated with a lower risk of AD (P = .004).

Conclusion:

Infants had a lower risk of developing AD if they had a longer stay in the NICU.

Keywords: atopic dermatitis, neonatal intensive care unit, prematurity, preterm

1 |. INTRODUCTION

Infantile AD is the first step in the proposed “atopic march,” followed by food allergies, asthma, and allergic rhinitis.1 In infants with AD, a compromised skin barrier exposes cutaneous immune cells to antigens and allergens, allowing for sensitization. This early sensitization places infants at risk for future allergic diseases, leading to the “atopic march.”2 Recent breakthroughs in AD have focused primarily on treatment,3 while there has been less focus on the prevention of AD. A multi-site randomized controlled trial demonstrated that consistent emollient use in infancy reduces the occurrence of AD by up to half,4 indicating that the neonatal period is a crucial, modifiable period in the pathogenesis of AD. The protective effect of emollient use may be due to repair of this barrier defect, which blocks antigen exposure.

Perhaps counterintuitively, preterm infants develop AD less often than full-term infants.514 Though some investigators have not found a significant relationship between prematurity and eczema,5,1519 a recent meta-analysis supports the proposed link in extremely preterm infants.20 Many of the studies included a predominantly Caucasian population, limiting the generalizability of the results.6,7,913,1519 A confounder in this relationship, lower birthweight has also been linked to a lower risk of atopic dermatitis.21 Other possible confounders, including mode of delivery, do not appear to be related to subsequent development of atopic dermatitis.19 These descriptive population-based studies do not offer insight into the causative mechanisms behind this association. Further research is needed to better understand the specific infant, maternal, and environmental factors contributing to this association.

Herein, we explore the infant and environmental factors that may contribute to the association between prematurity and atopic dermatitis, including mode of delivery, birthweight, gestation, and duration of stay in the neonatal intensive care unit (NICU). A better understanding of the mechanisms behind the lower rate of atopic dermatitis in preterm infants may provide a key clue in AD prevention. Identifying a modifiable cause of AD may also prevent the atopic march, thereby also reducing the incidence of food allergy, asthma, and allergic rhinitis.

2 |. METHODS

The University of Florida Institutional Review Board approved this study. All infants born at the University of Florida Shands Hospital (UF Health) from June 1, 2011, to April 30, 2017, were included in the study. Utilizing electronic health records (EHR), we then identified a sub-group who received primary care within our system past the initial birth visit. Children were included in the study sample if they had at least two well child visits, including one well child visit at or after 300 days of life. Retrospective review of the EHR included demographic, birth, maternal, and clinic data. A child was classified as having atopic dermatitis if ICD codes for atopic dermatitis were recorded in the EHR, including ICD-9 (691.8) and ICD-10 (L20.83, L20.84, L20.89, L20.9, L30.8, L30.9) codes.

Data were inspected for implausible values, missingness, and distributional form. Summary statistics (ie, means, standard deviations (SD), and frequencies) were computed for study variables. Exact 95% confidence intervals (CI) were calculated for the incidence of atopic dermatitis. Independent samples t tests or chi-square tests were used to compare groups with/without atopic dermatitis on continuous variables and categorical variables, respectively. We used logistic regression to simultaneously examine the association of the predictor variables of sex, delivery mode, gestational age, birthweight in grams, and length of stay in the NICU, with atopic dermatitis. The level of significance was set at 0.05, and all hypothesis testing was two-sided. SAS version 9.4 was used for all analyses.

3 |. RESULTS

In total, 4016 mother-infant dyads met criteria for inclusion in the study (Figure S1). Approximately 49% of the infants were female; 39.2% were black, 7.6% were Hispanic, 38.5% were white, and 14.7% were of other race/ethnicity. Sixty-five percent of deliveries were vaginal (see Table 1 for sample demographics).

TABLE 1.

Demographic dataa

Feature N (%) or Mean (SD)
Sex
 Female 1954 (48.8%)
 Male 2052 (51.2%)
Race
 Black 1574 (39.2%)
 White, non-Hispanic 1543 (38.5%)
 Hispanic 286 (7.1%)
 Asian 213 (5.3%)
 Multiracial 135 (3.4%)
 Other 262 (6.5%)
Payer
 Medicaid 2079 (51.9%)
 Private insurance 1310 (32.7%)
 Managed care 485 (12.1%)
 Self-pay 62 (1.6%)
 Medicare 39 (1%)
 Other 31 (<1%)
Delivery mode
 Vaginal 2425 (65.0%)
 Cesarean section 1309 (35.1%)
Mean Maternal age at delivery (y) 27.8 (5.8)
NICU stay
 No 3457 (86.1%)
 Yes 559 (13.9%)
Mean NICU length of stay (d) 3.9 (18.1)
Mean Gestational age (wk) 38.1 (3.3)
Gestational age
 Early preterm (<28 wk) 119 (3.1%)
 Very preterm (28 to <32 wk) 121 (3.2%)
 Moderate to late preterm (32 to <37 wk) 448 (11.7%)
 Early term (37 to <39 wk) 1089 (28.3%)
 Full term (39 to <41 wk) 1765 (46.0%)
 Late/post-term (41 wk or greater) 301 (7.8%)
Mean Birthweight (g) 3036.0 (757.5)
Birthweight (g)
 Extremely low birthweight (<1000 g) 131 (3.3%)
 Very low birthweight (1000 to <1500 g) 102 (2.5%)
 Low birthweight (1500 to <2500 g) 451 (11.2%)
 Normal birthweight (2500 to <4000 g) 3124 (77.8%)
 Macrosomia (>4000 g) 208 (5.2%)

Note: Demographic data including sex, race, and payer of the cohort, as well as maternal factors (age) and infant factors (delivery mode, gestational age, birthweight) are summarized.

a

Categorical responses may not sum to total sample size of 4016 due to missing data.

Atopic dermatitis was diagnosed in 26.6% of the sample (95% CI = [25.2%, 27.9%]). In bivariate analyses, delivery mode (P = .013), NICU stay (P < .001), gestational age (P = .001), and birthweight (P = .002) were significantly associated with incidence of atopic dermatitis. Infants had a higher risk of developing atopic dermatitis if they were delivered vaginally, did not stay in the NICU, had a longer gestation, or had a higher birthweight (Table 2). Extremely preterm (less than 28 weeks) and very preterm (28 to less than 32 weeks gestation) infants had the lowest rates of atopic dermatitis at 10.9% and 19.0%, respectively.

TABLE 2.

Relationship of infant factors with atopic dermatitisa

Feature Rate of atopic dermatitis N (%) or Mean (SD) P-value
Sex
 Female 512 (26.2%) .617
 Male 552 (26.9%)
Delivery mode
 Cesarean section 315 (24.1%) .013
 Vaginal 675 (27.8%)
Maternal age (y)
 No atopic dermatitis 28.0 (5.8) .007
 Atopic dermatitis 27.4 (6.0)
NICU stay
 No 960 (27.8%) <.001
 Yes 105 (18.8%)
NICU length of stay (d)
 No atopic dermatitis 4.6 (20.0) <.001
 Atopic dermatitis 2.0 (10.9)
Gestational age (wk)
 Early preterm (<28 wk) 13 (10.9%) .001
 Very preterm (28 to <32 wk) 23 (19.0%)
 Moderate to late preterm (32 to <37 wk) 129 (28.8%)
 Early term (37 to < 39 wk) 295 (27.1%)
 Full term (39 to < 41 wk) 486 (27.5%)
 Late/post-term (41 wk or greater) 72 (23.9%)
Birthweight (g)
 Extremely low birthweight (<1000 g) 19 (14.5%) .002
 Very low birthweight (1000 to <1500 g) 22 (21.6%)
 Low birthweight (1500 to <2500 g) 104 (23.1%)
 Normal birthweight (2500 to <4000 g) 869 (27.8%)
 Macrosomia (>4000 g) 51 (24.5%)

Note: Independent samples t tests or chi-square tests were used to compare groups with/without atopic dermatitis on continuous variables and categorical variables, respectively.

a

Categorical responses may not sum to total sample size of 4016 due to missing data.

In modeling atopic dermatitis with the predictor variables of delivery mode, gestational age, birthweight in grams, and length of stay in the NICU, we found that only length of stay in the NICU was related to the development of atopic dermatitis after adjusting for other variables in the model. Infants who spent more time in the NICU had a lower risk of developing atopic dermatitis (P = .004). Logistic regression coefficients and standard errors are reported in Table 3.

TABLE 3.

Modeling of atopic dermatitis with predictor variables

Atopic dermatitis
Logistic model parameter Logistic Regression Coefficient Estimate Standard Error P-value
Intercept −0.4826 0.7785 .535
Sex
 Female −0.0370 0.0771 .631
 Male [ref]
Delivery mode
 Cesarean section −0.1488 0.0828 .072
 Vaginal [ref]
NICU length of stay −0.0116 0.00400 .004
Birthweight (g)   0.000086 0.000090 .336
Gestational age −0.0183 0.0247 .459

Note: Logistic regression was used to simultaneously examine the association of the predictor variables of sex, delivery mode, gestational age, birthweight in grams, and length of stay in the NICU, with atopic dermatitis.

Maternal age was significantly associated with atopic dermatitis, with a mean maternal age of 27.4 years in infants with atopic dermatitis and a mean age of 28.0 years in infants without atopic dermatitis. This age difference, however, was not felt to be clinically significant. Maternal age was included in the original logistic regression model, however did not significantly change the model, and was excluded from the final model.

4 |. DISCUSSION

The lower rate of atopic dermatitis among premature infants is associated with duration of exposure to the neonatal intensive care unit. This highlights the importance of early life exposures, as this effect may be due to interactions between the microbiome, developing cutaneous immunity, and the evolving skin barrier of the preterm infant. The skin microbiome of premature infants differs from that of full-term infants, with more predominance of Staphylococcus species in the premature infant cutaneous microbiome.22 The early presence of Staphylococcus in the skin microbiome may confer protection. Kennedy et al23 found that early colonization with Staphylococcus was associated with a lower risk of atopic dermatitis at one year of age. It is possible that time spent in the NICU may be associated with increased likelihood of colonization with Staphylococcus in a dose-dependent manner; further studies are needed. This influence of the NICU environment on the establishment of the neonatal intestinal microbiome has been previously described.24 However, little is known about the influence of the NICU on the skin microbiome.

In the infanťs rapidly developing immune system, there is a delicate balance between the acquisition of tolerance and the development of antigen sensitization. It is possible that the timing of antigen exposure plays a role. Scharschmidt et al25 demonstrated that lack of cutaneous bacterial antigen exposure in murine infancy leads to subsequent inflammatory responses upon re-exposure. Tolerance develops when regulatory T cells rapidly migrate to the pups’ skin during the second week of life, in response to the cutaneous organisms. Exposure outside of this “critical window” does not lead to tolerance, but rather inflammation.26 Such a critical window of cutaneous immune tolerance may exist in humans, but the antigens of interest and timing of such a window are unknown.

Other aspects of exposure to the NICU environment may influence subsequent development of atopic dermatitis. Exposure to humidified isolettes in the NICU may influence skin barrier development, and thus the development of atopic dermatitis. Early infections and stimulation of the immune system may also play a role, which warrant a rigorous prospective study. Premature infants also have increased early exposure to antibiotics, and further research is needed to examine the association between timing of antibiotic exposure and atopic dermatitis.

While a critical window of immune tolerance and increased Staphylococcus exposure in the NICU may explain the lower rates of atopic dermatitis among preterm infants, this theory does not explain the higher rates of atopic dermatitis found in post-term12 and high birthweight21,27 infants. This result was not duplicated in the present study, as no significant difference was found in atopic dermatitis rates between the late preterm, early-term, full-term, and post-term groups. Larger multicenter studies are needed.

This study is strengthened by the racial diversity within the present cohort. The majority of studies examining the relationship between prematurity and eczema, including a recent systematic review and meta-analysis, did not comment on race.20 The linkage of maternal and infant medical records, which allowed us to examine both maternal and infant variables in their contribution to the development of infantile atopic dermatitis, was an additional asset.

This study was performed at a single tertiary medical center, and multicenter studies are needed to explore the relationship between prematurity and the subsequent development of eczema. Limitations of this study include the use of retrospective data in the reporting of patient outcomes (particularly diagnostic codes) and missing data (Tables 1 and 2). The limitations of electronic health records in research have been previously outlined.28 Of particular concern to this study is the limitation of diagnostic accuracy. While most pediatricians and pediatric subspecialists are comfortable with the diagnosis of atopic dermatitis, it may be difficult to discern atopic dermatitis from other common neonatal rashes, such as seborrheic dermatitis. Additionally, family history of atopy is not readily available in the EHR, but may contribute to the risk of AD.

This is the first study to identify an independent association between duration of NICU stay and a lower risk of atopic dermatitis. Knowledge gaps exist in our understanding of skin microbiome acquisition in the first weeks of life. A better understanding of host-microbe interactions of neonatal skin will lead to novel strategies for protection from atopic disease.

Supplementary Material

Supplemental Figure 1

ACKNOWLEDGMENTS

We acknowledge the University of Florida Integrated Data Repository (IDR) and the UF Health Office of the Chief Data Officer for providing the analytic data set for this project. Additionally, the research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under University of Florida Clinical and Translational Science Awards UL1TR000064 and UL1TR001427.

Funding information

National Center for Advancing Translational Sciences, Grant/Award Number: UL1TR000064 and UL1TR001427

Footnotes

CONFLICTS OF INTERESTS

Dr Schoch serves on the medical advisory board for Janssen Biotech, Inc. The other authors have no relevant conflicts of interest to disclose.

INSTITUTIONAL REVIEW BOARD APPROVAL

The Institutional Review Board at the University of Florida approved this study.

SUPPORTING INFORMATION

Additional supporting information may be found online in the Supporting Information section.

REFERENCES

  • 1.Lowe AJ, Leung DYM, Tang MLK, Su JC, Allen KJ. The skin as a target for prevention of the atopic march. Ann Allergy Asthma Immunol. 2018;120(2):145–151. [DOI] [PubMed] [Google Scholar]
  • 2.Dharmage SC, Lowe AJ, Matheson MC, Burgess JA, Allen KJ, Abramson MJ. Atopic dermatitis and the atopic march revisted. J Allergy Clin Immunol. 2014;69(1):17–27. [DOI] [PubMed] [Google Scholar]
  • 3.Renert-Yuval Y, Guttman-Yassky E. What’s new in atopic dermatitis. Dermatol Clin. 2019;37(2):205–213. [DOI] [PubMed] [Google Scholar]
  • 4.Simpson EL, Chalmers JR, Hanifin JM, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;134(4):818–823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Miyake Y, Tanaka K. Lack of relationship between birth conditions and allergic disorders in Japanese children aged 3 years. J Asthma. 2013;50(6):555–559. [DOI] [PubMed] [Google Scholar]
  • 6.Barbarot S, Gras-Leguen C, Colas H, et al. Lower risk of atopic dermatitis among infants born extremely preterm compared with higher gestational age. Br J Dermatol. 2013;169(6):1257–1264. [DOI] [PubMed] [Google Scholar]
  • 7.Tronnes H, Wilcox AJ, Lie RT, Markestad T, Moster D. The association of preterm birth with severe asthma and atopic dermatitis: a national cohort study. Pediatr Allergy Immunol. 2013;24(8):782–787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Haataja P, Korhonen P, Ojala R, et al. Asthma and atopic dermatitis in children born moderately and late preterm. Eur J Pediatr. 2016;175(6):799–808. [DOI] [PubMed] [Google Scholar]
  • 9.Olesen AB, Ellingsen AR, Olesen H, Juul S, Thestrup-Pedersen K. Atopic dermatitis and birth factors: historical follow up by record linkage. BMJ. 1997;314(7086):1003–1008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Egeberg A, Andersen YMF, Gislason G, Skov L, Thyssen JP. Neonatal risk factors of atopic dermatitis in Denmark - Results from a nationwide register-based study. Pediatr Allergy Immunol. 2016;27(4):368–374. [DOI] [PubMed] [Google Scholar]
  • 11.David TJ, Ewing CI. Atopic eczema and preterm birth. Arch Dis Child. 1988;63(4):435–436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Stanczyk-Przyluska A, Ligenza I, Wlazlowski J, Chlebna-Sokol D. Evaluation of allergic prevalence in prematurely born children. Pneumonol Alergol Pol. 2005;73(1):36–40. [PubMed] [Google Scholar]
  • 13.Bernsen RMD, de Jongste JC, Koes BW, Aardoom HA, van der Wouden JC. Perinatal characteristics and obstetric complications as risk factors for asthma, allergy and eczema at the age of 6 years. Clin Exp Allergy. 2005;35(9):1135–1140. [DOI] [PubMed] [Google Scholar]
  • 14.Moore MM, Rifas-Shiman SL, Rich-Edwards JW, et al. Perinatal predictors of atopic dermatitis occurring in the first six months of life. Pediatrics. 2004;113(3 Pt 1):468–474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Siltanen M, Wehkalampi K, Hovi P, et al. Preterm birth reduces the incidence of atopy in adulthood. J Allergy Clin Immunol. 2011;127(4):935–942. [DOI] [PubMed] [Google Scholar]
  • 16.Steffensen FH, Sorensen HT, Gillman MW, et al. Low birth weight and preterm delivery as risk factors for asthma and atopic dermatitis in young adult males. Epidemiol Camb Mass. 2000;11(2):185–188. [DOI] [PubMed] [Google Scholar]
  • 17.Katz KA, Pocock SJ, Strachan DP. Neonatal head circumference, neonatal weight, and risk of hayfever, asthma and eczema in a large cohort of adolescents from Sheffield, England. Clin Exp Allergy. 2003;33(6):737–745. [DOI] [PubMed] [Google Scholar]
  • 18.Kvenshagen B, Jacobsen M, Halvorsen R. Atopic dermatitis in premature and term children. Arch Dis Child. 2009;94(3):202–205. [DOI] [PubMed] [Google Scholar]
  • 19.Mallen CD, Mottram S, Wynne-Jones G, Thomas E. Birth-related exposures and asthma and allergy in adulthood: a population-based cross-sectional study of young adults in North Staffordshire. J Asthma. 2008;45(4):309–312. [DOI] [PubMed] [Google Scholar]
  • 20.Zhu T, Zhao J, Qu Y, Zhang L, Mu D. Association of very preterm birth with decreased risk of eczema: a systematic review and meta-analysis. J Am Acad Dermatol. 2018;78(6):1142–1148. [DOI] [PubMed] [Google Scholar]
  • 21.Panduru M, Salavastru CM, Panduru NM, Tiplica GS. Birth weight and atopic dermatitis: systematic review and meta-analyis. Acta Dermatovenerol Croat ADC. 2014;22(2):91–96. [PubMed] [Google Scholar]
  • 22.Younge NE, Araújo-Pérez F, Brandon D, Seed PC. Early-life skin microbiota in hospitalized preterm and full-term infants. Microbiome. 2018;6(1):98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Kennedy EA, Connolly J, Hourihane JO, et al. Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year. J Allergy Clin Immunol. 2017;139(1):166–172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Hartz LE, Bradshaw W, Brandon DH. Potential NICU environmental influences on the neonate’s microbiome: a systematic review. Adv Neonatal Care. 2015;15(5):324–335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Scharschmidt TC. Establishing tolerance to commensal skin bacteria: timing is everything. Dermatol Clin. 2017;35(1):1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Scharschmidt TC, Vasquez KS, Truong H-A, et al. A wave of regulatory T cells into neonatal skin mediates tolerance to commensal microbes. Immunity. 2015;43(5):1011–1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Sebõk B, Schneider I, Harangi F. Primary care paediatricians in Baranya county. Familiar and environmental factors influencing atopic dermatitis in the childhood. J Eur Acad Dermatol Venereol. 2006;20(4):418–422. [DOI] [PubMed] [Google Scholar]
  • 28.Brown ML. Can’t you just pull the data? The limitations of using of the electronic medical record for research. Paediatr Anaesth. 2016;26(11):1034–1035. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Figure 1

RESOURCES